Pro-resolving Effect of MAG-DHA in Cystic Fibrosis (PREMDIC)

NCT02518672 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
11
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

SCF Pharma

Collaborators